Atlas Trials

Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation

Clinical trial NCT02817750 · COMPLETED

Trial details

NCT number
NCT02817750
Sponsor
Biolab Sanus Farmaceutica
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2017-07-05
Primary completion
2018-02-22
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.